![]() |
6th ESACP Congress, Heidelberg, April 7-11, 1999 |
Parallel A6A: Tumor IV (Therapy & Prognosis) Sun.Apr.11 (DKFZ) 14.00-15.30h chair: JPA Baak (Alkmaar), P Herlin (Caen) |
A134
A099
A125
A102
A081
A088
14.00-14.15h:
THE RELEVANCE OF DNA PLOIDY, BIOCHEMICAL MARKERS AND CLINICOPATHOLOGICAL
FEATURES FOR PROGNOSIS PREDICTION IN BREAST CANCER
Theissig F, Kotzsch M, Dimmer V, Haroske G, Luther TH, Kunze KD
Institute of Pathology, Dresden University of Technology, Germany
14.15-14.30h:
MORPHOMETRIC QUANTITATION OF BRONCHIAL BIOPSIES AS INTERMEDIATE ENDPOINT
BIOMARKERS FOR LUNG CANCER CHEMOPREVENTION
MacAulay C, Klein-Parker H, Leriche J, Gazdar A *, Guillaud M,
Dawe C, Payne P, Korbelik J, Palcic B, Lam S
Cancer Imaging, BC Cancer Agency, Vancouver, Canada, * University
of Texas, Dallas, USA
14.30-14.45h:
PHOTOSENSITIZER ACCUMULATION, INTRACELLULAR LOCALISATION AND PHOTODYNAMIC
TREATMENT OF UROTHELIAL CELL LINES FOLLOWING INCUBATION WITH 5-AMINOLEVULINIC
ACID
Seidl J, Krieg R, Fickweiler S, Knüchel R
Institute of Pathology, University of Regensburg, Regensburg, Germany
14.45-15.00h:
ARE NUCLEAR TEXTURE FEATURES A SUITABLE TOOL FOR PREDICTING ORGAN CONFINEMENT
IN PROSTATIC ADENOCARCINOMAS?
Mairinger Th, Mikuz G, Gschwendtner A
Department of Pathology, University of Innsbruck, Innsbruck, Austria
15.00-15.15h:
PROGNOSTIC SIGNIFICANCE AND COMPARISON BETWEEN IMAGE CYTOMETRY AND
FLOW CYTOMETRY IN DNA PLOIDY DISTRIBUTION IN EPITHELIAL OVARIAN CANCER
STAGE 1
Kildal W 1, Kristensen GB 2, Abeler VM 1, Pettersen EO 1
Danielsen HE 1
1) Depts.Pathology and 2) Gynecologic Oncology, The Norwegian Radium
Hospital, Montebello Oslo, Norway
15.15-15.30h:
MIB-1 IMMUNOQUANTITATION IN CERVICAL INTRAEPITHELIAL
NEOPLASIA (CIN): A SENSITIVE MARKER FOR GRADING AND DIFFERENTIATION OF
BIOLOGIC UNFAVORABLE CIN-CASES
Kruse AJ, Broeckaert M, Baak JPA
Departments of Pathology, Free University Hospital, Amsterdam and Medical
Center Alkmaar, Netherlands
Last update: Apr.5, 1999